This federal contract award to AmerisourceBergen Drug Corp is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order has a ceiling value of $5,340.20 and is set to expire on December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, including the DLA, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/9/25, 12:59 AM